MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

07 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 3637.10 millions grew by 7.37 % from Rs. 3387.40 millions.Net Profit recorded in the quarter ended June 2026 rise to 45.29% to Rs. 961.50  millions  compared to R. 661.80 millions in corresponding previous quarter.Operating profit for the quarter ended June 2026 rose to 1034.80 millions as compared to 943.70 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3637.10 3387.40 7.37 3637.10 3387.40 7.37 14079.70 0.00 0.00
Other Income 38.80 40.30 -3.72 38.80 40.30 -3.72 173.40 0.00 0.00
PBIDT 1034.80 943.70 9.65 1034.80 943.70 9.65 4740.00 0.00 0.00
Interest 1.40 1.20 16.67 1.40 1.20 16.67 5.50 0.00 0.00
PBDT 1351.40 942.50 43.38 1351.40 942.50 43.38 4734.50 0.00 0.00
Depreciation 60.20 54.40 10.66 60.20 54.40 10.66 235.90 0.00 0.00
PBT 1291.20 888.10 45.39 1291.20 888.10 45.39 4498.60 0.00 0.00
TAX 329.70 226.30 45.69 329.70 226.30 45.69 1229.50 0.00 0.00
Deferred Tax 19.40 -3.10 -725.81 19.40 -3.10 -725.81 44.60 0.00 0.00
PAT 961.50 661.80 45.29 961.50 661.80 45.29 3269.10 0.00 0.00
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 0.00 0.00
PBIDTM(%) 28.45 27.86 2.13 28.45 27.86 2.13 33.67 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..